Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

CLL Society’s Official Statement on Evusheld, Boosters, and COVID-19 Therapies

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

After CLL Society’s most recent COVID-19 Webinar held on March 18, 2022, Is There Good News Ahead? Update on Omicron and Beyond / Available Therapies for COVID-19, we received hundreds of comments from those in the audience who are still having difficulty obtaining additional booster doses per the latest CDC guidance for the immunocompromised. Many asked what they can do when they are being told they are not eligible for additional recommended booster doses of the COVID-19 vaccine, Evusheld, or (even worse) when they came down with COVID-19 and were not prioritized by healthcare providers to receive live-saving therapeutic treatments.

CLL Society has put together a letter that you can print out and take with you, whether it be to a pharmacy, health department, or even your physician, to help reinforce the recommended guidance and clarify your need as an immunocompromised person with CLL/SLL.

We would also strongly encourage you to keep a copy of this letter within your COVID-19 Action Plan folder for quick and easy access.

Click to download and print a copy of CLL Society’s Official Statement on Evusheld, Boosters, and COVID-19 Therapies for those with CLL/SLL.

Keep learning and stay well.

Robyn Brumble, MSN, RN
Director of Scientific Affairs & Research
CLL Society